YU7196A - Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida - Google Patents

Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida

Info

Publication number
YU7196A
YU7196A YU7196A YU7196A YU7196A YU 7196 A YU7196 A YU 7196A YU 7196 A YU7196 A YU 7196A YU 7196 A YU7196 A YU 7196A YU 7196 A YU7196 A YU 7196A
Authority
YU
Yugoslavia
Prior art keywords
combination
phoscarnete
glucocorticoide
pharmaceutical formulation
formulation containing
Prior art date
Application number
YU7196A
Other languages
English (en)
Inventor
Nils-Erik Carlsson
Johan Harmenberg
Bengt Herslof
Ann Kristofferson
Karl Lundquist
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of YU7196A publication Critical patent/YU7196A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pronalazak se odnosi na jedan farmaceutski preparat koji sadrži kombinaciju foskarneta i jednog protivzapaljenjskog glukokortikoida, pomešanih sa nosačem na bazi galaktolipida i jednog polarnog rastvarača. Farmaceutski preparat se može koristiti za sprečavanje i/ili lečenje herpes virusnih infekcija kod sisara, uključujući i čoveka. Pronalazak se takodje odnosi na primenu tih farmaceutskih preparata u proizvodnji medikamenta za pomenuto sprečavanje ili lečenje infekcija.
YU7196A 1995-02-06 1996-02-06 Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida YU7196A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500112 1995-02-06

Publications (1)

Publication Number Publication Date
YU7196A true YU7196A (sh) 1998-09-18

Family

ID=20396817

Family Applications (1)

Application Number Title Priority Date Filing Date
YU7196A YU7196A (sh) 1995-02-06 1996-02-06 Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida

Country Status (18)

Country Link
US (1) US6068860A (sh)
EP (1) EP0809501A1 (sh)
JP (1) JPH11509515A (sh)
KR (1) KR19980701958A (sh)
AR (1) AR002274A1 (sh)
AU (1) AU715212B2 (sh)
CA (1) CA2211409A1 (sh)
DZ (1) DZ1965A1 (sh)
FI (1) FI973230A (sh)
HR (1) HRP960033A2 (sh)
IL (1) IL116910A0 (sh)
MA (1) MA23799A1 (sh)
NO (1) NO973611L (sh)
NZ (1) NZ301406A (sh)
TN (1) TNSN96023A1 (sh)
WO (1) WO1996024359A1 (sh)
YU (1) YU7196A (sh)
ZA (1) ZA96526B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN104117066B (zh) * 2014-07-16 2016-03-02 陈凌 外敷用抗甲状腺软膏的制备方法
US10759163B2 (en) 2014-10-27 2020-09-01 Hewlett-Packard Development Company, L.P. Printing device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0249561B1 (en) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU2823489A (en) * 1987-12-09 1989-07-05 Regents Of The University Of California, The Liposome-encapsulated anti-viral composition and method
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation

Also Published As

Publication number Publication date
ZA96526B (en) 1996-08-06
NO973611D0 (no) 1997-08-05
FI973230A0 (fi) 1997-08-05
TNSN96023A1 (fr) 2005-03-15
DZ1965A1 (fr) 2002-07-17
AR002274A1 (es) 1998-03-11
US6068860A (en) 2000-05-30
NO973611L (no) 1997-09-26
KR19980701958A (ko) 1998-06-25
FI973230A (fi) 1997-08-05
JPH11509515A (ja) 1999-08-24
IL116910A0 (en) 1996-09-12
AU715212B2 (en) 2000-01-20
CA2211409A1 (en) 1996-08-15
MA23799A1 (fr) 1996-10-01
EP0809501A1 (en) 1997-12-03
AU4682096A (en) 1996-08-27
NZ301406A (en) 1999-01-28
WO1996024359A1 (en) 1996-08-15
HRP960033A2 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
ES2116447T3 (es) Una composicion farmaceutica que contiene un sistema definido de lipidos.
ATE152630T1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
ATE240721T1 (de) Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
DE69739656D1 (de) 1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
DE3587434D1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
YU186291A (sh) Novi derivati hidroksamske kiseline i n-hidroksikarbamida
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
RU94040855A (ru) Фармацевтическая композиция на основе эмульсии масло в воде для местного применения, содержащая ароматическое активное вещество
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
AR007827A1 (es) 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos.
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
PT902789E (pt) Derivados de androsteno
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
HK1024422A1 (en) Antimicrobial cosmetic compositions
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
YU7196A (sh) Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida
CA2408541A1 (en) Treating eczema and/or psoriasis
SE8403659D0 (sv) Synergistic pharmaceutical composition
GEP20022840B (en) Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
DK227090D0 (da) Organisk guldkompleks til topisk anvendelse
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation